Nonpharmacologic reduction of periprocedural pain anxiety and prescription drug use
Award amount
$150,000Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- HYPNALGESICS, LLC
- Proposal award date
- 2017-07-01
- Contract end date
- 2018-12-31
- UEI
- DZJ8GHQ38A24
- Solicitation number
- PA16-302
- Topic code
- NCCIH
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Amelioration of Claustrophobia and Disruptive Patient Motion in MR Imaging
- Amelioration of Claustrophobia and Disruptive Patient Motion in MR Imaging
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Using scalable ultrasonic nano-emulsification to improve pharmacokinetic properties of the natural product curcumin.
- Botanical Drug for Chemotherapy Induced Nausea and Vomiting
- Leveraging Large Scale Bioinformatics and AI for Natural Product Drug Discovery and Target Selection
- Member Engagement Application for Personalized Arts-Based Social Prescriptions
- Evaluation of a novel soil-derived Mycobacterium as a nutritional supplement to promote stress resilience
Research funding history
3 SBIR/STTR records share this UEI (2011–2017). Reported award amounts total $1,791,524. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services